Group 1 - The company ST Kaili announced that the offer period for its share buyback has expired, with a total of 83,297 shares accepted from 26 accounts, which did not meet the target buyback amount of 71.7 million shares [1] - Following the completion of the buyback, Yongjin Investment will hold 50.18 million shares, representing 6.9989% of the company's total share capital [1] - The buyback is not intended to terminate the company's listing status, and the share distribution post-buyback still complies with the Shenzhen Stock Exchange listing requirements [1]

证券代码：300326 证券简称：ST 凯利 公告编号：2025-082 一、本次要约收购的基本情况 1.收购人：涌金投资控股有限公司 上海凯利泰医疗科技股份有限公司 关于涌金投资控股有限公司要约收购 结果暨股票复牌的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 特别提示： 1.上海凯利泰医疗科技股份有限公司（以下简称"公司"或"上市公司"， 股票简称：ST凯利，股票代码：300326）将于2025年8月21日（星期四）上午开 市起复牌。 2.在2025年7月17日至2025年8月15日要约收购期限内，最终有26个账户，共 计83,297股股份接受收购人涌金投资控股有限公司（以下简称"涌金投资"或"收 购人"）发出的要约，未超过预定收购的股份数量71,701,268股，收购人将依据 要约收购约定的条件全部收购预受要约的股份。 3.本次要约收购完成后，涌金投资持有公司50,183,297股股份，占公司总股 本的6.9989%。本次要约收购不以终止上市公司上市地位为目的，本次要约收购 后上市公司的股权分布将仍然符合深圳证券交易所规定的上市条件。 公司于20 ...

Core Points - ST Kelly announced that from July 17, 2025, to August 15, 2025, a total of 26 accounts accepted the tender offer from Yongjin Investment, amounting to 83,297 shares, which did not exceed the planned acquisition of 71.7013 million shares [1] - Following the completion of the tender offer, Yongjin Investment will hold 50.1833 million shares of the company, representing 6.9989% of the total share capital [1]

Core Points - The announcement details the completion of the tender offer by Yongjin Investment Holdings for Shanghai Kelly Tai Medical Technology Co., Ltd. [1] - The tender offer price is set at 5.18 CNY per share, targeting 71,701,268 shares, which represents 10% of the company's total share capital [1] - The tender offer period lasted for 30 calendar days, starting from the announcement date until August 15, 2025 [1] Company Actions - The company has applied for a trading suspension of its shares on the Shenzhen Stock Exchange, effective from August 18, 2025, until the announcement of the tender offer results [1] - The company will closely monitor the progress of the tender offer and fulfill its information disclosure obligations as per relevant laws and regulations [2]

Group 1 - ST凯利 announced a tender offer from Yongjin Investment for 71.70 million shares at a price of 5.18 yuan per share, representing 10% of the company's total equity [1] - The tender offer period ended on August 15, 2025, and the company has applied for a trading suspension starting August 18, 2025, pending confirmation of the offer results [1] - As of the announcement, ST凯利's revenue composition for 2024 is as follows: 56.82% from medical device manufacturing, 26.48% from instrument disinfection services, 14.48% from medical device trading, and 2.21% from other businesses [1] Group 2 - The current market capitalization of ST凯利 is 4.4 billion yuan [2]

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 上海凯利泰医疗科技股份有限公司（以下简称"公司"）于2025年7月16日 披露了涌金投资控股有限公司（以下简称"涌金投资"）送达的《上海凯利泰医 疗科技股份有限公司要约收购报告书》，涌金投资向除涌金投资以外的公司全体 持有无限售条件流通股（不包括公司回购专用证券账户持有的13,651股股份，下 同，截至本公告日，该部分回购股份已注销）的股东发出的部分要约收购（以下 简称"本次要约收购"），要约价格为5.18元/股，要约收购股份数量71,701,268 股，占公司总股本的10%。本次要约收购期限共计30个自然日，要约起始日期是 2025年7月17日，要约截止日期是2025年8月15日。 证券代码：300326 证券简称：ST 凯利 公告编号：2025-081 上海凯利泰医疗科技股份有限公司 关于涌金投资控股有限公司要约收购 期限届满暨股票停牌的公告 1 董事会 二○二五年八月十五日 2 截至2025年8月15日，本次要约收购期限已届满。鉴于本次要约收购结果需 进一步确认，根据《深圳证券交易所创业板股票上市规则》《深 ...

New Stock Issuance - China Shipbuilding (600150) has a buyback request period from August 13 to August 15, 2025[1] - Shenkai Co. (002633) has a tender offer period from July 29 to August 27, 2025[1] - ST Kelly (300326) has a tender offer period from July 17 to August 15, 2025[1] - Fushun Special Steel (600399) has a tender offer period from August 12 to September 10, 2025[1] - China Heavy Industry (601989) is undergoing a merger absorption[1] Market Alerts - Northern Long Dragon (301357) is experiencing severe abnormal fluctuations[1] - Great Wall Military Industry (601606) has a significant announcement on August 14, 2025[1] - ST Biological (000504) has a notable announcement on August 15, 2025[1] - ST South Property (002305) has a significant announcement on August 15, 2025[1] - ST Precision (600355) has a notable announcement on August 15, 2025[1]

New Stock Listings - Zhigao Machinery listed on August 14, 2025, with an issuance price of 17.41[1] - China Shipbuilding (stock code: 600150) has a buyout request period from August 13 to August 15, 2025[1] - Shinke Co. (stock code: 002633) has a tender offer period from July 29 to August 27, 2025[1] Tender Offers and Mergers - ST Kelly (stock code: 300326) has a tender offer period from July 17 to August 15, 2025[1] - Fushun Special Steel (stock code: 600399) has a tender offer period from August 12 to September 10, 2025[1] - China Heavy Industry (stock code: 601989) is involved in a merger announcement[1] Market Volatility - Longhua Technology (stock code: 603280) reported severe abnormal fluctuations[1] - Guochuang Gold Control (stock code: 002670) has been flagged for abnormal trading activity[1] - ST Keli Da (stock code: 600410) is also noted for significant price volatility[1]

New Stock Issuance - Hongyuan Co., Ltd. (stock code: 920018) issued shares at a price of 9.17 on August 11, 2025[1] - China Shipbuilding Industry Corporation (stock code: 600150) has a cash acquisition request period from August 13 to August 15, 2025[1] - ST Kelly (stock code: 300326) has a tender offer period from July 17 to August 15, 2025[1] Rights and Announcements - China Heavy Industry (stock code: 601989) has a cash option declaration period starting August 13, 2025[1] - Fushun Special Steel (stock code: 600399) has a tender offer period from August 12 to September 10, 2025[1] - North Long Dragon (stock code: 301357) has an announcement link for further details[1] Market Volatility - Several stocks, including ST Xifa (stock code: 000752) and ST Aowei (stock code: 002231), are under observation for significant price fluctuations[1] - The report highlights abnormal fluctuations in stocks such as ST Songfa (stock code: 603268) and ST Yancheng (stock code: 603063)[2]

Core Points - The company has completed the cancellation of 13,651 shares from its repurchase account, which accounts for 0.0019% of the total share capital, reducing the total shares from 717,026,333 to 717,012,682 [1][2][3] Summary by Sections Share Repurchase and Cancellation - The company has approved the cancellation of 13,651 shares from its repurchase account, following the necessary approval procedures [1][2] - The total amount allocated for share repurchase was between RMB 80 million and RMB 150 million, with a maximum repurchase price of RMB 12.00 per share [1] Reasons for Cancellation - The cancellation of shares is in accordance with the regulations set by the China Securities Regulatory Commission, which requires shares not used for employee stock ownership plans or equity incentive plans within three years to be canceled [2][3] Changes in Share Capital Structure - After the cancellation, the share capital structure will be as follows: - Restricted shares: 4,965,242 shares (0.69%) - Unrestricted shares: 712,047,440 shares (99.31%) - Total shares after cancellation: 717,012,682 shares [3] Impact of Cancellation - The cancellation of shares complies with relevant regulations and will not materially affect the company's operational performance or financial status, nor will it change the control of the company [3] Future Arrangements - The company will proceed with the necessary changes to its registered capital, amend its articles of association, and complete the relevant business registration and filing [3]